The rise of antibody pharmaceuticals and their future
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Phil Brereton.
Sir Greg Winter, Ph.D., FRS , (Master, Trinity College, University of Cambridge) is a British
biochemist and a pioneer of therapeutic monoclonal antibodies who invented techniques to humanise
antibodies using phage display for therapeutic uses. He founded Cambridge Antibody Technology
(acquired by Astrazeneca in 2006 for £702m) and Bicycle Therapeutics and is on the Scientific
Advisory Board of Covagen.
This talk is part of the Cambridge Science Summer School 2012 series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|